Short answer
Assembly Biosciences Inc (ASMB) filed an 8-K current report with the SEC on March 19, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Earnings announced for Q4 and full year ended December 31, 2025.
Assembly Biosciences Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Earnings announced for Q4 and full year ended December 31, 2025
- Detailed financials available in attached Exhibit 99.1 press release
- No summary metrics provided in filing; refer to exhibit for revenue, net income, guidance
- Material event signaling timely disclosure of 2025 financial performance to investors
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Get the next ASMB 8-K as it lands
Follow ASMB for push alerts, or ask the research agent what this filing means.